Literature DB >> 8801583

Effects of neonatal dopamine depletion on sensory inhibition in the rat.

K E Stevens1, J Luthman, E Lindqvist, R G Johnson, G M Rose.   

Abstract

Central dopamine systems appear to play an important role in sensory information processing. In particular, the filtering (or gating) of repetitive auditory stimuli is modulated by pharmacological manipulations that affect dopaminergic neurotransmission. The present study further addressed the role of dopamine in auditory gating. Three-day-old male Sprague-Dawley rats, pretreated with desipramine, received intracisternal injections of 6-hydroxydopamine (6-OHDA; 75 micrograms in 10 microliters) or the vehicle. At 4 months of age the rats were implanted for evoked potential recording and auditory gating was assessed using a paired click paradigm. Neonatally administered 6-OHDA did not alter gating in the adult rats. However, unlike for the control group, systemic amphetamine (1.83 mg/kg, IP) failed to disrupt gating in the treated rats. Apomorphine (1.0 mg/kg, SC) disrupted gating in both groups. Neonatal 6-OHDA treatment caused significant reductions in dopamine levels in the striatum, nucleus accumbens, and substantia nigra/ventral tegmental regions. There was an inverse relationship between substantia nigra/ ventral tegmental area dopamine levels and auditory gating. Overall, the results suggest that amphetamine-induced auditory gating loss requires presynaptic dopamine release, but that the deficiency occurs through postsynaptic dopamine receptor activation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8801583     DOI: 10.1016/0091-3057(95)02083-7

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  8 in total

1.  Convergence and divergence in the neurochemical regulation of prepulse inhibition of startle and N40 suppression in rats.

Authors:  Neal R Swerdlow; Mark A Geyer; Jody M Shoemaker; Gregory A Light; David L Braff; Karen E Stevens; Richard Sharp; Michelle Breier; Alaina Neary; Pamela P Auerbach
Journal:  Neuropsychopharmacology       Date:  2006-03       Impact factor: 7.853

Review 2.  Human and animal studies of schizophrenia-related gating deficits.

Authors:  G A Light; D L Braff
Journal:  Curr Psychiatry Rep       Date:  1999-10       Impact factor: 5.285

3.  Sensory and sensorimotor gating-disruptive effects of apomorphine in Sprague Dawley and Long Evans rats.

Authors:  Michelle R Breier; Brittanni Lewis; Jody M Shoemaker; Gregory A Light; Neal R Swerdlow
Journal:  Behav Brain Res       Date:  2010-01-18       Impact factor: 3.332

Review 4.  Pre-attentive processing and schizophrenia: animal studies.

Authors:  Bart A Ellenbroek
Journal:  Psychopharmacology (Berl)       Date:  2003-12-04       Impact factor: 4.530

5.  The effects of ketamine vary among inbred mouse strains and mimic schizophrenia for the P80, but not P20 or N40 auditory ERP components.

Authors:  Patrick M Connolly; Christina Maxwell; Yuling Liang; Jonathan B Kahn; Stephen J Kanes; Ted Abel; Raquel E Gur; Bruce I Turetsky; Steven J Siegel
Journal:  Neurochem Res       Date:  2004-06       Impact factor: 3.996

6.  Sustained extracellular signal-regulated kinase 1/2 phosphorylation in neonate 6-hydroxydopamine-lesioned rats after repeated D1-dopamine receptor agonist administration: implications for NMDA receptor involvement.

Authors:  Sophia T Papadeas; Bonita L Blake; Darin J Knapp; George R Breese
Journal:  J Neurosci       Date:  2004-06-30       Impact factor: 6.167

7.  Animal Models of Psychosis: Current State and Future Directions.

Authors:  Alexandra D Forrest; Carlos A Coto; Steven J Siegel
Journal:  Curr Behav Neurosci Rep       Date:  2014-06-01

8.  Role of beta2-containing nicotinic acetylcholine receptors in auditory event-related potentials.

Authors:  Noam D Rudnick; Christine Koehler; Marina R Picciotto; Steven J Siegel
Journal:  Psychopharmacology (Berl)       Date:  2008-10-18       Impact factor: 4.530

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.